Barclays
INSM icon

Barclays’s Insmed INSM Stock Holding History

Barclays’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1M Sell
275,731
-168,975
-38% -$26M 0.01% 765
2025
Q4 		$77.4M Buy
444,706
+330,510
+289% +$60.3M 0.02% 593
2025
Q3 		$16.4M Sell
114,196
-74,668
-40% -$9.15M ﹤0.01% 1346
2025
Q2 		$19M Sell
188,864
-90,406
-32% -$6.91M ﹤0.01% 1159
2025
Q1 		$21.3M Sell
279,270
-75,166
-21% -$5.75M 0.01% 1005
2024
Q4 		$24.5M Buy
354,436
+22,373
+7% +$1.61M 0.01% 1013
2024
Q3 		$24.2M Buy
332,063
+223,468
+206% +$16.5M 0.01% 969
2024
Q2 		$7.28M Sell
108,595
-119,341
-52% -$4.63M ﹤0.01% 1325
2024
Q1 		$6.18M Sell
227,936
-106,593
-32% -$2.98M ﹤0.01% 1712
2023
Q4 		$10.4M Buy
334,529
+162,728
+95% +$4.22M ﹤0.01% 1489
2023
Q3 		$4.34M Sell
171,801
-40,115
-19% -$917K ﹤0.01% 1401
2023
Q2 		$4.47M Sell
211,916
-725,024
-77% -$13.8M ﹤0.01% 1416
2023
Q1 		$16M Sell
936,940
-8,457
-0.9% -$164K 0.01% 951
2022
Q4 		$18.9M Buy
945,397
+521,346
+123% +$10.1M 0.01% 919
2022
Q3 		$9.13M Buy
424,051
+60,979
+17% +$1.46M 0.01% 885
2022
Q2 		$7.16M Buy
363,072
+341,164
+1,557% +$7.15M ﹤0.01% 1156
2022
Q1 		$515K Sell
21,908
-121,447
-85% -$2.82M ﹤0.01% 2881
2021
Q4 		$3.9M Buy
143,355
+59,564
+71% +$1.7M ﹤0.01% 1888
2021
Q3 		$2.31M Buy
83,791
+70,029
+509% +$1.84M ﹤0.01% 2222
2021
Q2 		$392K Sell
13,762
-138,015
-91% -$4.1M ﹤0.01% 3210
2021
Q1 		$5.17M Buy
151,777
+21,185
+16% +$810K ﹤0.01% 1493
2020
Q4 		$4.35M Sell
130,592
-58,999
-31% -$2.16M ﹤0.01% 1608
2020
Q3 		$6.09M Buy
189,591
+28,199
+17% +$811K ﹤0.01% 1286
2020
Q2 		$4.45M Buy
161,392
+27,815
+21% +$659K ﹤0.01% 1472
2020
Q1 		$2.14M Sell
133,577
-331,163
-71% -$7.85M ﹤0.01% 2221
2019
Q4 		$11.1M Buy
464,740
+395,409
+570% +$8.04M 0.01% 1318
2019
Q3 		$1.22M Buy
69,331
+12,119
+21% +$234K ﹤0.01% 3466
2019
Q2 		$1.47M Sell
57,212
-64,873
-53% -$1.81M ﹤0.01% 3272
2019
Q1 		$3.55M Buy
122,085
+117,055
+2,327% +$3.03M ﹤0.01% 1973
2018
Q4 		$66K Sell
5,030
-31,251
-86% -$499K ﹤0.01% 5306
2018
Q3 		$734K Buy
36,281
+6,295
+21% +$142K ﹤0.01% 3931
2018
Q2 		$709K Sell
29,986
-9,679
-24% -$249K ﹤0.01% 3612
2018
Q1 		$894K Buy
39,665
+12,304
+45% +$324K ﹤0.01% 3347
2017
Q4 		$853K Sell
27,361
-66,743
-71% -$1.97M ﹤0.01% 3268
2017
Q3 		$2.94M Buy
94,104
+85,526
+997% +$1.63M ﹤0.01% 1974
2017
Q2 		$147K Buy
8,578
+7,045
+460% +$120K ﹤0.01% 4623
2017
Q1 		$26K Sell
1,533
-2,379
-61% -$36.7K ﹤0.01% 5687
2016
Q4 		$52K Buy
3,912
+1,137
+41% +$15.5K ﹤0.01% 5133
2016
Q3 		$41K Buy
+2,775
New +$34.7K ﹤0.01% 5085
2016
Q2 		– Sell
-2,920
Closed -$35K – 6458
2016
Q1 		$35K Buy
2,920
+2,028
+227% +$26.7K ﹤0.01% 4961
2015
Q4 		$16K Sell
892
-15,845
-95% -$279K ﹤0.01% 5262
2015
Q3 		$302K Buy
16,737
+15,521
+1,276% +$387K ﹤0.01% 3791
2015
Q2 		$29K Sell
1,216
-1,047
-46% -$23.8K ﹤0.01% 5467
2015
Q1 		$45K Sell
2,263
-2,259
-50% -$39.8K ﹤0.01% 5355
2014
Q4 		$68K Buy
4,522
+2,818
+165% +$40K ﹤0.01% 5482
2014
Q3 		$22K Sell
1,704
-112,684
-99% -$1.7M ﹤0.01% 6426
2014
Q2 		$2.17M Buy
114,388
+7,886
+7% +$117K ﹤0.01% 2510
2014
Q1 		$2.02M Buy
106,502
+100,271
+1,609% +$1.91M ﹤0.01% 2537
2013
Q4 		$106K Sell
6,231
-1,401
-18% -$21.5K ﹤0.01% 5597
2013
Q3 		$115K Buy
7,632
+6,150
+415% +$78.1K ﹤0.01% 5511
2013
Q2 		$18K Buy
+1,482
New +$15.1K ﹤0.01% 6879

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays's INSM Position: Q1 2026 in Review

Barclays reduced its Insmed (INSM) stake by 38% in Q1 2026, selling an estimated $26M and leaving 275,731 shares worth $45.1M. The position accounts for 0.01% of the portfolio, ranked #765.

Barclays first reported a position in INSM in Q2 2013 and has held it in 51 quarters since. The position peaked at $77.4M in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Barclays held 275,731 shares of Insmed worth $45.1M as of Q1 2026.
  • Barclays sold 168,975 Insmed shares in Q1 2026, an estimated $26M.
  • Insmed made up 0.01% of Barclays's portfolio in Q1 2026, its #765 holding.
  • Barclays first reported a position in Insmed in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Insmed position peaked at $77.4M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.